AbbVie’s $2.1 billion acquisition of Capstan Therapeutics aims to advance in vivo CAR-T therapies, transforming autoimmune ...

AbbVie has agreed to buy Capstan Therapeutics for up to $2.1 billion, expanding its pipeline with a potential first-in-class ...

AbbVie gains control of an in vivo CAR-T therapy that could overcome limitations with currently approved autologous ...

The pharmaceutical industry may find its footing in 2025 as various factors, including President Trump's policies, events such as JPM, and scrutiny from the Federal Trade Commission, shape its future.

The dermatology market in the U.S. is at a pivotal moment of transformation, with spending poised to climb from $40.55 billion in 2023 to $70 billion by 2030. This unprecedented growth mirrors past ...

Regenerative medicine includes the generation and use of therapeutic stem cells, tissue engineering and the production of artificial organs. Latest Research and Reviews.

The UAB Department of Emergency Medicine is an integral part of one of the nation's largest health systems. Nationally known for our compassionate care, cutting-edge research, and comprehensive ...

CME activities, cases, challenges, videos, and more teaching and learning tools from the New England Journal of Medicine.

Welcome and thank you for considering the New England Journal of Medicine (NEJM) as a venue for your work.. As the oldest continuously-published medical journal, our mission since 1812 has been to ...

Nanomedicine is a branch of medicine that applies the knowledge and tools of nanotechnology to the prevention and treatment of disease. Nanomedicine involves the use of nanoscale materials, such ...

1 Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, ... FDA Approves Skyrizi for Ulcerative Colitis news; ...

FDA Approves Skyrizi (Risankizumab) for Ulcerative Colitis Fact-Checked on June 20, 2024. ... Yuying Luo, MD, is an assistant professor of medicine at Mount Sinai West and Morningside in New York ...